Suppression of cell proliferation and telomerase activity in 4-(hydroxyphenyl)retinamide-treated mammary tumors

Carcinogenesis

Volumn 20, Issue 5, 1999, Pages 879-883

  Bednarek, Andrezj ^a   Shilkaitis, Anne ^b   Green, Albert ^b   Lubet, Ronald ^c   Kelloff, Gary ^c   Christov, Konstantin ^b   Aldaz, C Marcelo ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BROXURIDINE; FENRETINIDE; METHYLNITROSOUREA; TELOMERASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BREAST CARCINOMA; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME REPRESSION; FEMALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT;

EID: 0032928318     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/20.5.879     Document Type: Article

References (24)

1. Rhyu,M.S. (1995) Telomeres, telomerase, and immortality. J. Natl Cancer Inst., 87, 884-902.
2. Holt,S.E., Shay,J.W. and Wright,W.E. (1996) Refining the telomere-telomerase hypothesis of aging and cancer. Nature Biotechnol., 14, 836-839.
3. Kim,N.W., Piatyszek,M.A., Prouse,K.R., Harley,C.B., West,M.D., Ho,P.L.C., Coviello,G.M., Wright,W.E., Weinrich,S.L. and Shay,J.W. (1994) Specific association of human telomerase activity with immortal cells and cancer. Science, 266, 2011-2015.
4. Hiyama,E., Gollahon,L., Kataoka,T., Kuroi,K., Yokoyama,T., Gazdar,A.F., Hiyama,K., Piatyszek,M.A. and Shay,J.W. (1996) Telomerase activity in human breast tumors. J. Natl Cancer Inst., 88, 116-122.
5. Bednarek,A., Sahin,A., Brenner,A.J., Johnston,D.A. and Aldaz,C.M. (1997) Analysis of telomerase activity levels in breast cancer: positive detection at the in situ breast carcinoma stage. Clin. Cancer Res., 3, 11-16.
6. Kolquist,K.A., Ellisen,L.W., Counter,C.M., Meyerson,M., Tan,L.K., Weinberg,R.A., Haber,D.A. and Gerald,W.L. (1998) Expression of TERT in early premalignant lesion and a subset of cells in normal tissues. Nature Genet., 19, 182-186.
7. Bednarek,A.J, Chu,Y. and Aldaz,C.M. (1998) Constitutive telomerase activity in cells with tissue renewing potential from estrogen-regulated rat tissues. Oncogene, 16, 381-385.
8. Varon,D., Jiang,C., Hedican,C., Dome,J.S., Umbricht,C.B., Carey,L.A., Thompson,H.J. and Sukumar,S. (1997) Telomerase activity in the normal and neoplastic rat mammary gland. Cancer Res., 57, 5605-5609.
9. Sharma,H.W., Sokoloski,J.A., Perez,J.R., Maltese,J.Y, Sartorelli,A.C., Stein,C.A., Nichols,G., Khaled,Z., Telang,N.T. and Narayanan,R. (1997) Differentiation of immortal cells inhibits telomerase activity. Proc. Natl Acad. Sci. USA, 92, 12343-12346.
10. Albanell,J., Han,W., Mellado,B., Gunawardane,R., Scher,H.I., Dmitrovsky,E. and Moore,M.A. (1996) Telomerase activity is repressed during differentiation of maturation-sensitive but not resistant human tumor cell lines. Cancer Res., 56, 1503-1508.
11. Faraoni,I., Turriziani,M., Naci,G., DeVeccis,L., Shay,J.W., Bonmassar,E. and Graziani,G. (1997) Decline in telomerase activity as a measure of tumor cell killing by antineoplastic agents in vitro. Clin. Cancer Res., 3, 579-585.
12. Hoos,A., Hepp,H.H., Kaul,S., Ahlert,T., Bastert,G. and Wallwiener,D. (1998) Telomerase activity correlates with tumor aggressiveness and reflects therapy effect in breast cancer. Int. J. Cancer, 79, 8-12.
13. Moon,R.C., Thompson,H.J., Becci,P.J. et al. (1979) N-4 (hydroxyphenyl) retinamide, a new retinoid for prevention of breast cancer in the rat. Cancer Res., 39, 1339-1346.
14. Moon,R.C., Mehta,R.G. and Rao,K.V.N. (1994) Retinoids and cancer in experimental animals. In Sporn,M.B., Roberts,A.B. and Goodman,D.S. (eds) The Retinoids: Biology, Chemistry, and Medicine, 2nd edn. Raven Press, New York.
15. Dowlatshahi,K., Mehta,R.G., Thomas,C.F., Dinger,N.J. and Moon,M.S. (1989) Therapeutic effect of 4-HPR on N-methyl-N-nitrosourea-induced rat mammary cancer. Cancer Lett., 47, 187-192.
16. Bischoff,E.D., Gottardis,M., Moon,T.E., Heyman,R.A. and Lamph,W.W. (1998) Beyond tamoxifen: the retinoid × receptor selective ligand LGD 1069 (Targretin) causes complete regression of mammary carcinomas. Cancer Res., 58, 479-484.
17. Christov,K., Swanson,S., Guzman,R., Thordarson,G., Talamantes,F. and Nandi,S. (1996) Cell proliferation and apoptosis during mammary carcinogenesis in pituitary isografted mice. Carcinogenesis, 16, 101-106.
18. Piatyszek,M.A., Kim,N.W., Weinrich,S.L., Hiyama,K., Hiyama,E., Wright,W.E. and Shay,J.W. (1995) Detection of telomerase activity in human cells and tumors by a telomeric repeat amplification protocol (TRAP). Methods Cell Sci., 17, 1-15.
19. Bednarek,A, Budunova,I., Slaga,T.J. and Aldaz,C.M. (1995) Increased telomerase activity in mouse skin premalignant progression. Cancer Res., 55, 4566-4569.
20. Christov,K., Aldaz,M., Weinstein,I.B., Mehta,R.G. and Lubet,R. (1998) Effect of 4-HPR on cell proliferation and telomerase activity in MNU carcinogenesis model. Proc. Am. Assoc. Cancer Res., 39, 359.
21. Green,A., Shilkaitis,A. and Christov,K. (1998) 4-HPR selectively suppresses the development and progression of ductal hyperplastic lesions and CIS in mammary carcinogenesis. Proc. Am. Assoc. Cancer Res., 39, 358.
22. Holt,S.E. Aisner,D.L., Shay,J.W. and Wright,W.E. (1997) Lack of cell cycle regulation of telomerase activity in human cells. Proc. Natl Acad. Sci. USA, 94, 10687-10692.
23. Xu,D., Gruber,A., Peterson,C. and Pisa,P. (1996) Suppression of telomerase activity in HL60 cells after treatment with differentiating agents. Leukemia, 10, 1354-1357.
24. Lee,P.P., Lee,M.T., Darcy,K.M. and Ip,M.M. (1995) Modulation of normal mammary epithelial cell proliferation, morphogenesis, and functional differentiation by retinoids: a comparison of the retinobenzoic acid derivative RE80 with retinoic acid. Endocrinology, 136, 1707-1717.